Immunocore
IMCR
133 hedge funds and large institutions have $1.5B invested in Immunocore in 2025 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 45 increasing their positions, 41 reducing their positions, and 13 closing their positions.
138% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 13
15% more funds holding
Funds holding: 116 → 133 (+17)
7% more capital invested
Capital invested by funds: $1.4B → $1.5B (+$95.7M)
10% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 41
0.63% more ownership
Funds ownership: 94.45% → 95.08% (+0.63%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
75% less call options, than puts
Call options by funds: $9.21M | Put options by funds: $36.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$37.9M |
| 2 |
Primecap Management
Pasadena,
California
|
+$33.9M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$31.8M |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$17.9M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$12.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$59.6M |
| 2 |
GA
General Atlantic
New York
|
-$37.4M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$27.4M |
| 4 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
-$22.3M |
| 5 |
AC
Armistice Capital
New York
|
-$9.32M |
IMCR Hedge Fund Activity: Q2 2025 in Review
133 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Immunocore (IMCR) for Q2 2025, worth a combined $1.5B — up 6.8% from $1.4B a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new IMCR positions and 13 closed out — a net gain of 18 holders — while 45 added to existing stakes and 41 trimmed.
The largest buyer was Bellevue Group, adding an estimated $37.9M. The largest seller was Wellington Management Group, cutting an estimated $59.6M.
- 133 institutional investors held Immunocore (IMCR) as of Q2 2025, up from 116 in Q1 2025.
- Funds reported $1.5B of Immunocore stock for Q2 2025, up 6.8% quarter-over-quarter.
- 31 funds opened new Immunocore positions in Q2 2025 and 13 closed out, a net change of +18 holders.
- The largest Immunocore buyer in Q2 2025 was Bellevue Group, an estimated $37.9M added.
- The largest Immunocore seller in Q2 2025 was Wellington Management Group, an estimated $59.6M sold.
Based on aggregated 13F filings for Q2 2025.